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1. Introduction
Amphipathic helices play crucial roles in modulating the 
interaction of proteins and peptides with membranes (Segrest 
et al. 1974; Kaiser and Kezdy 1984, 1987; Segrest et al. 1990; 
Epand et al. 1995; Huang et al. 1995; Phoenix et al. 1998; 
Johnson and Cornell 1999; Phoenix and Harris 2002; Cornell 
and Taneva 2006). Due to the distribution of polar and apolar 
residues on opposite faces of the helix, these peptides prefer 
aqueous–membrane interfaces. The average hydrophobic 
moment and average hydrophobicity values that would 
favour surface activity have been described by Eisenberg et 
al. (1982a, b). Based on the angle subtended by the polar face 
and distribution of anionic and cationic residues in the polar 
face, amphipathic helices have been classifi ed into different 
categories (Segrest et al. 1990; Phoenix et al. 1998; Phoenix 
and Harris 2002). Helices that cause membrane lysis belong 
to class L and those that bind to lipids but are not lytic, such 
as those occurring in apolipoproteins, are classifi ed as class 
A. Interest in amphipathic helices has further stemmed 
from the observation that a large number of linear host-
defence antibacterial peptides form helices in membrane 
environments that are amphipathic in nature (Saberwal and 
Nagaraj 1994; Oren and Shai 1998; Matsuzaki 1998, 1999; 
Sitaram and Nagaraj 1999; Tossi et al. 2000; Giangaspero 
et al. 2001). 
Modulation of the amphipathic character of helical 
peptides has been observed to result in altered haemolytic 
and/or antibacterial activities (Degrado et al. 1981; Agawa 
et al. 1991; Dathe et al. 1996; Kiyota et al. 1996; Wieprecht 
et al. 1997a, b; Uematsu and Matsuzaki 2000), underlining 
the importance of amphipathicity for interaction with 
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membranes. In fact, model peptides composed of only 
hydrophobic and cationic residues, suitably engineered 
to result in amphipathicity that would favour membrane 
interaction, do exhibit membrane activity (Degrado et al. 
1981; Agawa et al. 1991; Blondelle and Houghten 1992; 
Kiyota et al. 1996). However, naturally occurring host-
defence peptides that interact with membranes have marked 
differences in their amino acid composition, lengths, 
amphipathicity and propensity for α-helical conformation 
(Saberwal and Nagaraj 1994; Oren and Shai 1998; 
Matsuzaki 1998, 1999; Sitaram and Nagaraj 1999; Tossi et 
al. 2000; Giangaspero et al. 2001). We have analysed protein 
structures in the Protein Databank (PDB) and delineated 
helices with a varying mean hydrophobic moment (<μH>) 
and hydrophobicities (<H>) (Sharadadevi et al. 2005). The 
analysis indicates that a large number of these helices would 
be surface-active. We have shown earlier that synthetic 
peptides corresponding to such helices with <μH> and <H>, 
which would favour ‘surface activity’, have antibacterial 
and/or haemolytic activities (Sharadadevi et al. 2005). 
The structures of these peptides, as observed in the X-ray 
structure of their parent proteins, are shown in fi gure 1. 
In the present study, we investigated how these peptides 
interact with model membranes. The bee-venom peptide 
melittin, whose model-membrane activity has been studied 
extensively (reviewed in Dempsey 1990; Raghuraman and 
Chattopadhyay 2007), and a potent analogue of the frog-skin 
antibacterial peptide magainin, MSI-78 (Maloy and Kari 
1995), have been included for comparison. 
2. Experimental procedures
2.1 Peptide synthesis
The following peptides were manually synthesised on 
Fmoc-amide handle crowns from Chiron, Australia, 
employing Fmoc chemistry (Atherton and Sheppard 
1989) as described earlier (Sharadadevi et al. 
2005): Pihf (Ac-RDAKELVELFFEEIRRAL-am), 
Pc3c (Ac-WYSEMKRNVQRLERAIEE-am), Pqc7 (Ac-LK-
DVEEAQQKIINIIRRL-am), Pc9k (Ac-NRLARHFRDIAG-
RVNQRL-am), Pill (Ac-KQLIRFLKRLDRNLWGLA-am), 
Pbuy (Ac-FRKLFRVYSNFLRGKLKL-am), and MSI-
78. Melittin obtained from Sigma Chemical Co., USA, 
and purifi ed by high-performance liquid chromatography 
(HPLC) was used for the experiments.
2.2 Far UV circular dichroism measurements
Spectra were recorded in a JASCO-J-815 spectropolarimeter 
using a quartz cell of 1 mm path length at 25°C. Data are 
represented as mean residue ellipticities (MRE). The lipids 
used for the preparation of lipid vesicles were 1-palmitoyl-
2-oleoyl-sn-glycerophosphocholine (PC) and 1-palmitoyl-2-
oleoyl-sn-glycerophosphoglycerol (PG). Small unilamellar 
vesicles (SUV) were prepared by sonicating a dispersion of 
the required lipid in 5 mM HEPES (pH 7.4) with 150 mM 
NaCl to clarity in a Branson sonifier.
2.3 Calcein release
The ability of the peptides to perturb membranes was 
determined by the release of the entrapped calcein at self-
quench concentrations on a Hitachi 4500 spectrofl uorimeter. 
The lipids used for the preparation of lipid vesicles were PC 
and PG. A lipid fi lm composed of the required phospholipid 
was dispersed in 5 mM HEPES (pH 7.4) containing 70 mM 
calcein and passed through a Lipofast extruder (100 nm pore 
fi lter) (MacDonald et al. 1991) to obtain dye-encapsulated 
large unilamellar vesicles (LUV). The excess free dye was 
separated from the liposomes by gel fi ltration on a Sephadex 
G-75 column (elution buffer: 5 mM HEPES pH 7.4/150 mM 
NaCl, 5 mM EDTA). Release of the dye after addition of the 
peptide was continuously monitored by setting the excitation 
and emission wavelengths at 490 and 520 nm, respectively. 
Complete release of the dye was obtained by addition of 
Triton X-100 (0.1% v/v). The self-quenching property of the 
marker dye calcein was exploited in order to elucidate the 
induced release from the entrapped liposomes. To determine 
the mechanism of membrane permeabilisation, the dynamic 
self-quenching factor Q (Schwarz and Arbuzova 1995; 
Arbuzova and Schwarz 1999) was obtained as follows: after 
the calcein-containing LUV were mixed with the peptide, 
aliquots were drawn at different time points (different stages 
of effl ux) and loaded on a Sephadex G-75 column for gel 
fi ltration. The vesicle fraction was separated from the leaked 
dye and the dynamic self-quenching factor Q was obtained 
by measuring fl uorescence intensity before (F
b
) and after (F
a
) 
the addition of Triton X-100, as denoted by Q = F
b
/F
a
. To the 
remaining solution in the cuvette, Triton X-100 was added to 
lyse the vesicles completely. The apparent retention ‘E’ was 
calculated according to the following equation: E=(F
t 
−
 
F)/
(F
t 
− F
o
), where F and F
t 
denote the intensity of fl uorescence 
before and after addition of the detergent, respectively. 
Fluorescence from intact vesicles is denoted by F
o
. 
2.4 Diffusion potential dissipation assay
The model membrane permeabilising ability was determined 
by monitoring the dissipation of the diffusion potential set 
up in lipid vesicles by valinomycin (Sims et al. 1974). K+ 
(100 mM KCl) was entrapped in the lipid vesicles. During 
the experiment the vesicles were diluted in 5 mM HEPES 
buffer, pH 7.4, containing 100 mM NaCl, followed by serial 
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addition of the cyanine dye (diS-C
3
-5), valinomycin and the 
peptides. The excitation and emission wavelengths were 
620 and 670 nm, respectively. Percentage of fl uorescence 
recovery F was calculated using the equation F=(F
t 
− F
o
)/(F
f 
− F
t
) x 100, where F
t
 is the fl uorescence after addition of the 
peptide, F
o
 after addition of valinomycin, and F
f 
is the total 
fl uorescence.
2.5 Tryptophan fl uorescence
Peptide–lipid interaction was studied by monitoring 
changes in the fl uorescence properties of the Trp-containing 
peptides upon titration with lipid LUV. The emission 
spectra were recorded between 300 and 400 nm, with the 
excitation wavelength set at 280 nm, with 5 nm slit widths. 
All measurements were carried out on a Hitachi 4500 
fl uorescence spectrometer. LUV were obtained by passing 
through polycarbonate fi lters (pore size=100 nm) in a 
Lipofast extruder. In the quenching experiments, increasing 
amounts of the two quenchers, KI and acrylamide, were 
added to peptide–lipid solutions. The KI solution contained 
1 mM Na
2
S
2
O
3
 to prevent I3- formation. The data were 
analysed according to the Stern–Volmer equation. Another 
quencher, N-bromosuccinimide (NBS), was also included in 
the study. NBS (8 uM) was added to the lipid-bound peptide 
and the spectra of the residual fl uorescence were recorded 
after 10 min. 
3. Results
Examination of the structures shown in fi gure 1 indicates 
that the polar face of the Pbuy and Pill helices is composed 
of cationic amino acids. In peptides Pc9k, Pqc7, Pc3c and 
Pihf, both cationic and anionic amino acids are present in 
the polar face. The sequence, mean hydrophobic moment, 
average hydrophobicity and net charge at neutral pH of 
Figure 1. Structures of the 18-residue peptides as observed in their parent proteins. Their Protein Data Bank (PDB) IDs are 1buy, 1ill, 
1c9k, 1qc7, 1c3c and 1ihf, respectively. The net charge at neutral pH is indicated in parentheses. C and N denote the carboxy- and amino- 
terminal ends. The N-terminal acetyl and C-terminal amide modifi cations are not included. Red, blue and green colours denote O, N and C 
atoms, respectively. Structures were generated using PyMOL (Delano W L [2002], Delano Scientifi c, San Carlos, CA, USA)
Pbuy(+6) Pill(+4) Pc9k(+4) Pq 7(+1)c P c(0)c3 P (-1)ihf
N
C
Table 1. Primary structure and physical properties of amphipathic peptides
Sequence of the peptides <μH> <H> Net charge Mean <H>
 nonpolar
Ac-RDAKELVELFFEEIRRAL-am Pihf 0.72 –0.21 –1 0.51 
Ac-WYSEMKRNVQRLERAIEE-am Pc3c 0.69 –0.45   0 0.26
Ac-LKDVEEAQQKIINIIRRL-am Pqc7 0.71 –0.2 +1 0.45 
Ac-NRLARHFRDIAGRVNQRL-am Pc9k 0.71 –0.5 +4 0.49 
Ac-KQLIRFLKRLDRNLWGLA-am Pill 0.75 –0.19 +4 0.39 
Ac-FRKLFRVYSNFLRGKLKL-am Pbuy 0.69 –0.19 +6 0.32
GIGAVLKVLTTGLPALISWIK RKRQQ- am Melittin 0.55 a  –0.09 +6
GIGKFLKKAKKFGKAFVKILKK-am MSI-78 0.75 a –0.18 +9
a<μH > are the highest mean values obtained for a window of 18 residues.
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the six 18-residue peptides, along with that of MSI-78 and 
melittin, are shown in table 1. Zwitterionic PC vesicles and 
anionic PC/PG vesicles, mixed in a ratio of 1:1 were used, as 
membrane activity of melittin and MSI-78 show considerable 
variation against zwitterionic and anionic vesicles, which 
has been attributed to differences in their orientation in these 
lipid vesicles (Benachir and Lafl eur 1995; Ladokhin and 
White 2001; Ramamoorthy et al. 2006).
3.1 Circular dichroism
The circular dichroism (CD) spectra of peptides were 
recorded in buffer and in the presence of increasing 
concentrations of lipid vesicles (fi gure 2). The structural 
propensities of the peptides vary to different extents. In 
buffer, Pill, Pbuy and Pc9k show spectra with a minimum 
at ~205 nm and a small shoulder at ~225 nm. These features 
indicate largely unordered conformation with only a small 
fraction populating helical conformation (Manning et al. 
1988; Woody 1995; Venyaminov and Yang 1996). The 
shoulder at ~225 nm is more pronounced in Pqc7, indicating 
a greater fraction populating ordered conformation. Pihf 
shows a single minimum at ~217 nm, characteristic of a 
β-structure. 
In the presence of lipids, Pill and Pbuy show minima 
at ~205 nm and ~225 nm, with a crossover at 200 nm, 
characteristic of helical conformation (Manning et al. 
1988; Woody 1995; Venyaminov and Yang 1996). Pc9k 
shows similar features in the presence of PC/PG vesicles, 
but PC vesicles do not induce ordered conformation. The 
helical content does not increase for Pqc7 in the presence 
of PC and PC/PG lipid vesicles. Pihf shows two minima in 
PC/PG vesicles, suggesting transition from β-structure in 
aqueous medium to helical conformation. In PC vesicles,
β-structure predominates. The CD data indicate that peptides 
with a high net positive charge tend to fold into helical 
conformation in the presence of negatively charged vesicles. 
In all the peptides, no further changes were observed in the 
CD spectra at peptide–lipid ratios >1:20 or 1:40. Pc3c, with 
a net charge of 0, did not yield good spectra in the presence 
of lipids, probably due to precipitation. 
3.2 Membrane permeabilisation
In order to determine whether the amphipathic peptides 
can permeabilise model membranes, release of entrapped 
calcein was monitored at different peptide:lipid (P/L) ratios. 
The ability of the peptides to release calcein from PC LUV 
is shown in fi gure 3. Among the 18-residue peptides, Pill 
is most effective in causing release of calcein, followed 
by Pbuy, Pqc7 and Pc9k. Initially, leakage occurs rapidly, 
followed by a slower rate of release, except in the case of 
Pbuy, where the release is instantaneous and complete. 
The effi cacy of Pill is comparable to melittin. In spite of its 
greater positive charge of +6 (similar to melittin), Pbuy is 
less effective. MSI-78, the magainin analogue, is the most 
potent among all the peptides in causing calcein release. 
Figure 2. Far-UV circular dichroism (CD) spectra of the 18-
residue peptides upon titration with lipid vesicles. Panels on the 
left are with PC small unilamellar vesicles (SUV) and panels on 
the right with PC/PG (1:1) SUV. Peptide concentration = 25 μM. 
(o---o) represents the spectrum of peptide in buffer. Lipid/peptide 
(L/P) ratios are indicated against each trace. PC, 1-palmitoyl-2-
oleoyl-sn-glycerophosphocholine; PG, 1-palmitoyl-2-oleoyl-sn-
glycerophosphoglycerol.
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All the peptides are less effective in causing the release of 
calcein from PC/PG (1:1) vesicles (fi gure 4). Ten-fold more 
peptide is necessary to cause a similar extent of dye release in 
PC/PG, compared with PC LUV. Even melittin and the highly 
cationic MSI-78 are less effective in causing calcein release 
as compared with PC vesicles. It has been shown that calcein 
release by melittin is inhibited in the presence of negatively 
charged lipids. This inhibition is presumed to result from 
peptide binding to the anionic charged surface (Benachir and 
Lafl eur 1995; Ladokhin and White 2001), which prevents 
the formation of defects, thereby inhibiting calcein release. 
Interaction of MSI-78 with lipids is also dependent on the 
composition of the lipid (Ramamoorthy et al. 2006). Despite 
the requirement of a larger concentration of peptide to cause 
release of calcein, an initial rapid release is observed in the 
presence of Pbuy, Pill, MSI-78 and melittin. Peptides Pqc7 
and Pc9k are not as effective in causing the release of calcein. 
Also, their activities against both PC and PC/PG vesicles are 
comparable, indicated by the similar range of P/L ratios to 
cause the effl ux of calcein from both neutral and acidic lipids 
(fi gures 3 and 4). Peptides Pihf and Pc3c did not cause release 
of calcein even at a P/L ratio of 1:1. 
In order to assess the mechanism of perturbation and 
calcein release, the rate of initial release (at t=1 min) was 
examined as a function of P/L ratios (fi gure 5). There are 
differences in the rates of calcein release by the peptides. 
Illustrated in the inset is the expanded portion of the X-axis 
at very low P/L ratios. It is clearly evident from the steep 
increase in the initial rates that Pill displays effi ciency, 
comparable to MSI-78 and melittin, whereas the other three 
peptides exhibit lower potencies. The curves do not suggest 
cooperativity or formation of aggregates on the bilayer 
surface. This is further confi rmed in the log–log plots in 
which slopes of ~1 were obtained (data not shown). Hence, 
the permeabilisation process does not appear to arise due to 
the formation of transmembrane channels. 
The mechanism of calcein release was examined, as 
described in Experimental procedures. The data presented 
in table 2 indicate an ‘all-or-none’ mechanism of vesicle 
disruption by Pill and Pc9k. The data also suggest ‘all-or-
none’ release for Pqc7 from PC/PG vesicles and some extent 
of graded release from PC vesicles. Pbuy exhibits ‘all-or-
none’ release from both PC and PC/PG vesicles.
It is possible that the low activity of some of the peptides 
could arise as a result of less extensive membrane damage, 
and hence a lesser extent of calcein effl ux. Therefore, the 
ability of peptides to dissipate the diffusion potential created 
by valinomycin was examined (fi gure 6). Peptides Pill, 
Pbuy, MSI-78 and melittin, although they caused the release 
of calcein from PC/PG vesicles at high P/L ratios (fi gure 5), 
Figure 3. Release of calcein from PC large unilamellar vesicles (LUV) at different peptide–lipid ratios.  Lipid = 30 μM.  Release obtained 
with Triton X-100 indicated by dash on the right side Y-axis was taken as 100%. Peptide–lipid ratios are indicated above each trace.
%
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Figure 4. Release of calcein from PC/PG (1:1) large unilamellar vesicles (LUV) at different peptide–lipid ratios.  Lipid = 30 μM. Release 
obtained with Triton X-100 indicated by a dash on the right side Y axis was taken as 100%. Peptide–lipid ratios are indicated above each 
trace. PC, 1-palmitoyl-2-oleoyl-sn-glycerophosphocholine; PG, 1-palmitoyl-2-oleoyl-sn-glycerophosphoglycerol.
Figure 5. Plots of rate of initial calcein release as a function of peptide–lipid ratio. (A) PC and (B) PC/PG (1:1) . t = 1 min. Key: 
(Δ---Δ), MSI-78; (o—o), Pbuy; (■--■), Pill; (x-x), Pc9k; (♦---♦), Pqc7 and (●-----●) melittin. Inset: expanded portion of the X-axis. PC, 
1-palmitoyl-2-oleoyl-sn-glycerophosphocholine; PG, 1-palmitoyl-2-oleoyl-sn-glycerophosphoglycerol.
Model membrane activity of helical amphipathic peptides 245
J. Biosci. 34(2), June 2009
could dissipate diffusion potential from PC/PG vesicles at 
considerably lower P/L ratios. Pbuy, in spite of possessing 
a higher charge, exhibited a lower ability to dissipate the 
diffusion potential compared with Pill. In fact, Pqc7 showed 
considerable activity at P/L ratios as low as 0.075 against 
PC/PG vesicles (fi gure 6B), unlike PC where no further 
dissipation of diffusion potential was observed above a P/L 
ratio of 0.02 (fi gure 6A). Pc9k was also moderately active in 
permeabilising vesicles, resulting in the effl ux of calcein, as 
well as causing dissipation of the diffusion potential. Even 
at a P/L ratio of 0.1, only ~20% fl uorescence recovery was 
observed (data not shown) in both PC and PC/PG vesicles, 
unlike the other four membrane-active peptides, viz. MSI-
78, melittin, Pill and Pbuy.
3.3 Tryptophan fl uorescence
As the emission properties of Trp are sensitive to the 
surrounding environment, the fl uorescence of Trp in two of 
the peptides that have Trp, viz., the very active Pill and the 
inactive Pc3c, were examined in the absence and presence of 
lipid vesicles. Variations in the emission spectrum of Trp in 
buffer and in the presence of lipid vesicles are presented in 
fi gure 7 A–D. Increasing concentrations of lipid vesicles were 
added to a fi xed concentration of the peptide (4 μM). Both the 
peptides exhibit a λ
max
 ~355 nm in buffer, indicating exposure 
of Trp to an aqueous environment. Quenching of fl uorescence 
intensity with no blue shift was observed when titrated with 
PC vesicles. In the presence of PC/PG vesicles, a blue shift in 
λ
max
,
 
with
 
a concomitant increase in intensity were observed 
for Pill, whereas a decrease in fl uorescence intensity was 
observed for Pc3c. The maximum blue shift of approximately 
12 nm was observed for Pill, up to a P/L ratio of 1:30 (shown 
in fi gure 7). A further increase in P/L ratio did not cause any 
further changes in both λ
max 
and fl uorescence intensity.
The localisation of Trp in the lipid bilayer in these 
peptides was examined by accessibility to quenchers, such 
as I-, acrylamide and NBS. Quenching of fl uorescence in 
Pc3c by KI was comparable both in the absence and in the 
presence of lipid vesicles, refl ected by the superimposable 
lines (fi gure 7E). The Trp in Pill was shielded from I- (fi gure 
7F) and acrylamide (fi gure 7G) in both PC and PC/PG 
vesicles, with inaccessibility more pronounced in the latter. 
The normal accessibility factor (naf) values, which are a 
measure of the accessibility of the fl uorophore in lipids with 
respect to free peptide in buffer, were found to be around 
0.25–0.26 in the presence of PC, whereas it was in the range 
of 0.04–0.06 in anionic PC/PG. Such low values of naf 
indicate that the Trp is almost completely shielded from the 
Figure 6. Dissipation of diffusion potential in lipid vesicles induced by peptides. Panel A: PC and panel B for PC/PG (1:1) LUV. Peptides 
were added to lipid vesicles in K
+
-free buffer pre-equilibriated with the fl uorescent dye diS-C3-(5) and valinomycin. Key: (Δ---Δ), MSI-78; 
(o—o), Pbuy; (■--■), Pill; (♦---♦), Pqc7 and (●-----●), melittin. PC, 1-palmitoyl-2-oleoyl-sn-glycerophosphocholine; PG, 1-palmitoyl-2-
oleoyl-sn-glycerophosphoglycerol.
Table 2. Modes of peptide-induced calcein leakage
Peptide PC PC/PG (1:1)
Ea Qa E Q
Pqc7 0.91 0.17 0.85 0.11
0.42 0.23 0.55 0.11
0.34 0.27 0.40 0.17
Pc9k 0.80 0.15 0.80 0.11
0.59 0.20 0.61 0.11
Pill 0.96 0.08 0.85 0.12
0.59 0.11 0.60 0.14
0.32 0.10 0.43 0.20
Pbuy 0.70 0.12 0.90 0.26
0.19 0.16 0.60 0.25
a: E and Q are apparent retention and quenching factors, 
respectively, at different time points.
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quenchers. As the quenching curves almost overlap in the 
presence and absence of lipid vesicles (fi gure 7E), in Pc3c 
the naf would be almost equal to 1, indicating considerable 
exposure to the quencher KI. It is also conceivable that 
since the Trp in Pc3c occurs at the extreme N-terminus, it is 
exposed to an aqueous environment, even though the rest of 
the peptide chain is associated with lipid vesicles. When the 
emission spectra of Pill, after quenching with acrylamide, 
were examined, a distinct blue shift of approximately 10 
nm was observed, indicating a population of peptides, with 
Trp in a moderately hydrophobic environment (data not 
shown). The susceptibility of Trp to oxidation by NBS in 
the presence of PC and PC/PG vesicles at varying P/L ratios 
is shown in fi gure 8 A–D. In buffer, the fl uorescence of Trp 
was quenched within 2−3 min on treatment with NBS (data 
not shown). In the presence of PC/PG vesicles, considerable 
fl uorescence was retained even after treatment with NBS for 
30 min, indicating that Trp is not accessible to NBS. Whereas 
a small decrease in fl uorescence intensity was observed at a 
P/L ratio of 1:30 (fi gure 8A, trace 3) compared with buffer 
(fi gure 8A, trace 1), the value was higher when P/L=1:100 
(fi gure 8B, trace 3) compared with buffer (fi gure 8B, trace 
1). The blue shift obtained on addition of lipid vesicles 
(fi gure 8A, B, trace 2) was observed to remain unchanged in 
the emission spectrum of Trp that was not oxidised (fi gure 
8A, B, trace 3), indicating a hydrophobic location of Trp. 
In the presence of PC vesicles, irrespective of the P/L ratio, 
there was further quenching upon addition of NBS to lipid-
bound vesicles (fi gure 8C, D).
4. Discussion
The six peptides described in table 1 are helical segments 
derived from globular proteins (fi gure 1). These peptides 
show a propensity for helical conformation in the presence 
of zwitterionic and anionic lipids, albeit to different extents. 
They display varying degrees of membrane perturbation, as 
indicated by their ability to induce calcein release or cause 
dissipation of the diffusion potential. The helical wheel 
diagrams, which have been used extensively to explain the 
membrane activity of amphipathic peptides (Segrest et al. 
1990; Epand et al. 1995; Phoenix and Harris 2002) shown 
in fi gure 9, indicate that the most active peptide Pill has 
a polar angle ≤180°, in which the boundary residues are 
both cationic, or one cationic and the other an uncharged 
polar residue. Three out of the fi ve cationic residues are 
Arg. This pattern is different from the canonical class L 
amphipathic helix, which has a characteristic narrow, acute 
polar face comprising Lys or Arg residues (Segrest et al. 
Figure 7. Tryptophan fl uorescence spectra of peptides Pill and Pc3c.  (A, C) PC large unilamellar vesicles (LUV); (B, D), PC/PG LUV. 
Increasing concentrations of lipid vesicles were added to a fi xed concentration of peptide (4 μM).  Data shown are for a peptide–lipid (P/
L) ratio of 1:30 where maximal changes were observed. Thin and thick lines denote absence and presence of lipid vesicles, respectively. 
Stern–Volmer plots showing quenching of Trp fl uorescence of Pc3c by KI (panel E), Pill by KI (panel F), and Pill by acrylamide (panel 
G). Initial concentration of peptide = 4 μM.  Lipid = 400 μM. Key: (■--■) buffer, (o—o) PC LUV and (♦---♦) PC/PG (1:1) LUV. PC, 1-
palmitoyl-2-oleoyl-sn-glycerophosphocholine; PG, 1-palmitoyl-2-oleoyl-sn-glycerophosphoglycerol.
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1990; Epand et al. 1995). Yet, this observed pattern does 
impart considerable model membrane-perturbing ability 
comparable with melittin and MSI-78 (whose polar face is 
composed of only Lys residues, fi gure 9) against PC vesicles. 
Peptides Pbuy and Pc9k, despite having net positive charges 
of +6 and +4, respectively, are less active than Pill. In fact, 
Pbuy also has three Arg and two Lys residues in the polar 
face, similar to Pill. Nevertheless, the presence of a Lys 
also in the apolar face in Pbuy appears to attenuate the 
membrane perturbation compared with the presence of Asp 
in Pill, which may be facilitating the interactions with lipid 
vesicles. Also, the contiguous stretch of Leu residues that are 
stacked in the apolar face in Pill (fi gure 1) could be a feature 
that contributes to its higher activity. Peptide Pc9k with all 
the fi ve Arg residues in the polar face is signifi cantly less 
membrane-active compared with Pill and Pbuy. Lack of Lys 
residues, occurrence of an acidic Asp residue, and a large 
number of other uncharged polar residues on the polar face 
of Pc9k could reduce the charge density, thereby resulting 
in this attenuation of activity. The mean hydrophobicity 
per residue of the non-polar face in the peptides, using the 
consensus scale of Eisenberg et al. (1982b) is shown in 
table 1. Membrane-active peptides have a lower average 
hydrophobicity value compared with inactive peptides, with 
the exception of Pc3c. In Pihf, Pc3c and Pqc7, although there 
are several cationic residues in the polar face, there are also 
anionic residues and uncharged polar residues that appear to 
play a role in decreasing the membrane-perturbing activity. 
All the peptides studied perturb negatively charged lipids 
to a lesser extent. A higher concentration of melittin was 
required to cause the release of entrapped markers from 
lipid vesicles containing anionic phospholipids (Benachir 
and Lafl eur 1995; Ladokhin and White 2001). Benachir and 
Lafl eur (1995) have argued that binding of melittin to the 
charged surface prevents the formation of defects that allow 
leakage. Ladokhin and White (2001) have attributed the 
lower activity to the inability of melittin to translocate PG-
containing vesicles and adopt a transmembrane orientation. 
The low activity against PC/PG vesicles could arise because 
of binding to the bilayer surface, which prevents the 
formation of defects, as proposed for melittin (Benachir and 
Lafl eur 1995; Ladokhin and White 2001). 
More than one model has been proposed to rationalise 
permeabilisation of model membranes by amphipathic 
helical peptides. According to the toroidal pore model 
proposed for the interaction of magainin and analogues 
with model membranes, formation of a pore composed of a 
peptide–lipid supramolecular complex and translocation of 
peptide across the lipid bilayer is responsible for membrane 
permeabilisation (Matsuzaki 1999). In the ‘carpet model’, 
peptides bind to the membrane surface and cover it like a 
carpet. Membrane destabilisation occurs due to electrostatic 
interaction between the positively charged peptides and 
the negatively charged membrane surface, as well as 
hydrophobic interactions (Shai 1999). Certain amphipathic 
helical peptides corresponding to the helices of plasma 
apolipoprotein A-1 stabilise membranes (Segrest et al. 
1990). The ‘snorkel model’ proposed for the insertion of 
this class of peptides (class A amphipathic peptides), in 
which the cationic residues occur at the boundary of the 
apolar/polar face and anionic residues towards the centre 
of the polar face, indicate that the alkyl side chains of 
Lys/Arg, which occur in the boundary of the apolar/polar 
face, are associated with the hydrophobic region of the lipid 
bilayer. The positively charged amino groups in contact
with water extend to a location similar to the negatively 
charged carboxyl groups (Segrest et al. 1990; Epand et al. 
1995). Our results, taken together from the different assays, 
suggest that these 18-residue peptides exert membrane 
activity in lipid vesicles by a process of membrane 
destabilisation, as described in the ‘carpet model’, rather 
than by the formation of pores due to peptide aggregates. 
It is unlikely that the lack of membrane-disrupting activity 
of some peptides is due to membrane stabilisation, as
in the case of class A amphipathic peptides, as the 
arrangement of residues in the polar face is not similar to 
those of class A amphipathic peptides. The occurrence of 
anionic amino acid residues in the polar face could result 
Figure 8. Quenching of Trp in Pill on treatment with NBS. 
(A, B) In the presence of PC/PG (1:1) LUV; (C, D) in the 
presence of PC large unilamellar vesicles (LUV). Traces 1, 2 
and 3 denote fl uorescence spectra of peptide in buffer, lipid-
bound and lipid-bound after N-bromosuccinimide (NBS) 
modifi cation. Concentration of peptide = 4 μM; NBS = 8 μM. 
Lipid concentration = 120 μM (A and C) and 400 μM (B and D) 
to yield peptide–lipid ratios of 1:30 and 1:100, respectively. PC, 
1-palmitoyl-2-oleoyl-sn-glycerophosphocholine; PG, 1-palmitoyl-
2-oleoyl-sn-glycerophosphoglycerol.
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in a relatively weaker affi nity for the membrane surface 
and consequently ineffective membrane destabilisation. 
A recent study on 17-residue model peptides highlights 
the importance of hydrophobic moment in modulating the 
partitioning of an amphipathic helix into the lipid bilayer 
interface (Fernandez-Vidal et al. 2007). 
These authors concluded from their study that helical 
amphiphilicity is far more important than hydrophobicity 
for binding to membrane surfaces. The free energy of 
partitioning of melittin into PC vesicles was lower compared 
with its diastereomer, which had a lower propensity
for helical conformation in PC vesicles (Ladokhin and
White 1999). Hence, lower membrane activity of the two
18-residue peptides, viz., Pqc7 and and Pc9k, can be 
attributed to lower helical propensity in the presence of 
POPC vesicles, which would result in unfavourable free 
energy of partitioning.
Although our analysis is confi ned to only six peptides, 
it covers a broad range of net charge and composition
of residues on the polar and apolar faces. Our results indicate 
that the amphipathic helical segments present in proteins 
could have a distribution of polar and apolar residues that 
is different from the canonical classes. The widely varying 
model membrane-perturbing activities of the six peptides 
indicate how variation of amino acids in the polar face region 
can modulate activity. Hence, amphipathic helices, which are 
a part of proteins, with a pattern of amino acid distribution 
different from those observed in class L, A and others, could 
help in providing newer insights into peptide–membrane 
interactions and their self-aggregating properties could also 
lead to the generation of novel organised assemblies.
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